Skip to main content

Surgical Treatment of Meniere’s Disease

  • Chapter
  • First Online:
Diagnosis and Treatment of Vestibular Disorders

Abstract

Meniere’s disease was first described by Prosper Meniere in 1861 [1]. The classic disease description includes the tetrad of hearing loss, tinnitus, aural fullness, and vertigo spells. The disease tends to fluctuate and can be said to be predictably unpredictable. The spells can last from minutes to hours. Attacks can be associated with nausea, vomiting, headache, and fatigue. Medical management is sufficient for a majority of patients, but those who are recalcitrant may be a candidate for surgical intervention. Currently, a variety of surgical techniques are employed for patients with Meniere’s disease who have failed medical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meniere P. Sur une forme de surdite grave dependant d’une lesion de l’oreille interne. Gaz Med de Paris. 1861;16:29.

    Google Scholar 

  2. Dandy W. Effects on hearing after subtotal section of the cochlear branch of the auditory nerve. Bull Johns Hopkins Hosp. 1934;55:240–3.

    Google Scholar 

  3. Dandy W. The surgical treatment of Ménière’s disease. Surg Gynecol Obstet. 1941;72:421–5.

    Google Scholar 

  4. Lake R. Removal of semicircular canals in a case of unilateral aural vertigo. Lancet. 1904;1:421.

    Google Scholar 

  5. Cawthorne TE. The treatment of Ménière’s disease. J Laryngol Otol. 1943;58:363–71.

    Article  Google Scholar 

  6. Portmann G. Vertigo, surgical treatment of opening of the saccus endolymphaticus. Arch Otolarygol Head Neck Surg. 6:309–19.

    Google Scholar 

  7. House WF. Subarachnoid shunt for drainage of endolymphatic hydrops. Laryngoscope. 1962;72:713–29.

    CAS  PubMed  Google Scholar 

  8. Schuknecht HF. Cochlear endolymphatic shunt. Am J Otol. 1984;5:546–8.

    CAS  PubMed  Google Scholar 

  9. Pou AM, Hirsch BE, Durrant JD, et al. The efficacy of tympanic electrocochleography in diagnosis of endolymphatic hydrops. Am J Otol. 1996;17(4):607–11.

    CAS  PubMed  Google Scholar 

  10. Fischer LM, Derebery J. Oral steroid treatment for hearing improvement in Ménière’s disease and endolymphatic hydrops. Otol Neurotol. 2012;33(9):1685–91.

    Article  Google Scholar 

  11. Balkany. The bilateral aspects of Meniere’ disease: an underestimated entity. Otolaryngol Clin N Am. 1980;12:603–9.

    Google Scholar 

  12. Shea JJ Jr. The role of dexamethasone or streptomycin perfusion in the treatment of Ménière’s disease. Otolaryngol Clin N Am. 1997;30(6):1051.

    Google Scholar 

  13. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17.

    Article  CAS  Google Scholar 

  14. Chandrasekhar SS, Rubinstein RY, Kwartler JA. Dexamethasone pharmacokinetics in the inner ear: comparison and use of facilitation agents. Otolaryngol Head Neck Surg. 2000;122(4):521–8.

    CAS  PubMed  Google Scholar 

  15. McRackan TR, Best J, Pearce EC, Bennett ML, Dietrich M, Wanna GB, Haynes DS, Labadie RF. Intratympanic dexamethasone as a symptomatic treatment for Meniere’s disease. Otol Neurotol. 2014;35(9):1638–40.

    Article  Google Scholar 

  16. Thomsen J, Bretlau P, Tos M, et al. Placebo effect in surgery for Ménière’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol. 1981;107(5):271.

    Article  CAS  Google Scholar 

  17. Glasscock ME, et al. What I think of sac surgery in 1989. Am J Otol. 1989;10(3):230–3.

    PubMed  Google Scholar 

  18. Pillsbury HC 3rd, Arenberg IK, Ferraro J, Ackley RS. Endolymphatic sac surgery. The Danish sham surgery study: an alternative analysis. Otolaryngol Clin N Am. 1983;16(1):123–7.

    Google Scholar 

  19. Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Head Neck Surg. 2000;122(3):340.

    Article  CAS  Google Scholar 

  20. Telischi FF, Luxford WM. Long-term efficacy of endolymphatic sac surgery for vertigo in Ménière’s disease. Otolaryngol Head Neck Surg. 1993;109(1):83.

    Article  CAS  Google Scholar 

  21. Kato BM, LaRouere MJ, Bojrab DI, et al. Evaluating quality of life after endolymphatic sac surgery: the Meniere’s disease outcomes questionnaire. Otol Neurotol. 2004;25:339–44.

    Article  Google Scholar 

  22. Sood A, Lambert P, et al. Endolymphatic sac surgery for Meniere’s disease: a systematic review and meta-analysis. Otol Neurotol. 2014;35:1033Y1045.

    Article  Google Scholar 

  23. Paparella MM. Revision of endolymphatic sac surgery for recurrent Meniere’s disease. Otolaryngol Clin North Am. 2002;35(3):607–19.

    Article  Google Scholar 

  24. Paparella MM1, Sajjadi H. Endolymphatic sac revision for recurrent Menière’s disease. Am J Otol. 1988;9(6):441–7.

    CAS  PubMed  Google Scholar 

  25. Fowler EP. Streptomycin treatment for vertigo. Trans Am Acad Ophthalmol Otolaryngol. 1948;52:293–301.

    PubMed  Google Scholar 

  26. Ohmori WH. Mechano-electrical transduction currents in isolated vestibular hair cells of the chick. J Physiol. 1985;359:189–217.

    Article  CAS  Google Scholar 

  27. Waguespack J, Ricci A. Aminoglycoside ototoxicity: permeant drugs cause permanent hair cell loss. J Physiol. 2005;567:359–60.

    Article  CAS  Google Scholar 

  28. Williams S, Zenner H, Schacht J. Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res. 1987;30:11–8.

    Article  CAS  Google Scholar 

  29. Schuknecht HP. Ablation therapy for the relief of Meniere’s disease. Laryngoscope. 1956;66:859.

    Article  CAS  Google Scholar 

  30. Graham MD, Sataloff RT, Kemink JL. Titration streptomycin therapy for bilateral Meniere’s disease: a preliminary report. Otolaryngol Head Neck Surg. 1984;92(4):440–7.

    Article  CAS  Google Scholar 

  31. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Menière’s disease. Rationale for extremely low dose therapy. Acta Otolaryngol. 1991;111(4):671–6.

    Article  CAS  Google Scholar 

  32. Nedzelski J, Chiong C, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Meniere’s disease: update of an ongoing study. Am J Otol. 1993;13:278–82.

    Google Scholar 

  33. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993;4(3):289–94.

    Article  CAS  Google Scholar 

  34. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere’s disease: vestibular signs that specify completion of therapy. Am J Otol. 1999;20(2):209.

    CAS  PubMed  Google Scholar 

  35. Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Meniere’s disease. Laryngoscope. 2000;110(8):1298.

    Article  CAS  Google Scholar 

  36. Dandy WE. Ménière’s disease: its diagnosis and method of treatment. Arch Surg. 1928;16:1127–52.

    Article  Google Scholar 

  37. Dandy WE. Treatment of Ménière’s disease by section of only the vestibular portion of the acoustic nerve. Bull Johns Hopkins Hosp. 1933;53:52–5.

    Google Scholar 

  38. House WF. Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope. 1961;71:1363.

    Article  CAS  Google Scholar 

  39. Silverstein H, Norrell H. Retrolabyrinthine surgery: a direct approach to the cerebellopontine angle. Otolaryngol Head Neck Surg. 1980;88:462–9.

    Article  CAS  Google Scholar 

  40. Rosenberg S, Silverstein H, Hoffer M, et al. Hearing results after posterior fossa vestibular neurectomy. Otolaryngol Head Neck Surg. 1996;114:32–7.

    Article  CAS  Google Scholar 

  41. Silverstein H, Norrell H, Smouha EE. Retrosigmoid-internal auditory canal approach vs. retrolabyrinthine approach for vestibular neurectomy. Otolaryngol Head Neck Surg. 1987;97(3):300–7.

    Article  CAS  Google Scholar 

  42. Tewary AK, Riley N, Kerr AG. Long-term results of vestibular nerve section. J Laryngol Otol. 1998;112(12):1150–3.

    Article  CAS  Google Scholar 

  43. Pappas DG Jr, Pappas DG Sr. Vestibular nerve section: long-term follow-up. Laryngoscope. 1997;107(9):1203–9.

    Article  Google Scholar 

  44. Silverstein H, Norrell H, Rosenberg S. The resurrection of vestibular neurectomy: a 10-year experience with 115 cases. J Neurosurg. 1990;72(4):533–9.

    Article  CAS  Google Scholar 

  45. Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin N Am. 2002;35(3):655–73. ISSN 0030-6665

    Article  Google Scholar 

  46. Setty BS, et al. Fully endoscopic Retrosigmoid vestibular nerve section for refractory Meniere disease. J Neurol Surg B. 2016;77(04):341–9.

    Article  Google Scholar 

  47. House JW, Brackmann DE. Tinnitus: surgical management. Ciba Found Symp. 1981;85:204–16.

    CAS  PubMed  Google Scholar 

  48. Hammerschlag PE, Schuknecht HF. Transcanal labyrinthectomy for intractable vertigo. Arch Otolaryngol. 1981;107:152–6.

    Article  CAS  Google Scholar 

  49. Graham MD. Transmastoid labyrinthectomy: further experiences with the indications, complications, and early postoperative results. J Laryngol Otol. 1981;95:1205–11.

    Article  CAS  Google Scholar 

  50. Kemink JL, Telian SA, Graham MD, Joynt L. Transmastoid labyrinthectomy: reliable surgical management of vertigo. Otolaryngol Head Neck Surg. 1989;101(1):5–10.

    Article  CAS  Google Scholar 

  51. Zwolan TA, Shepard NT, Niparko JK. Labyrinthectomy with cochlear implantation. Am J Otol. 1993;14(3):220–3.

    CAS  PubMed  Google Scholar 

  52. MacKeith SA, Bottrill ID, Ramsden JD. Simultaneous labyrinthectomy with cochlear implantation in patients with bilateral Ménière’s disease. Ann Otol Rhinol Laryngol. 2014;123(7):485–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jackson, N.M., LaRouere, M.J. (2019). Surgical Treatment of Meniere’s Disease. In: Babu, S., Schutt, C., Bojrab, D. (eds) Diagnosis and Treatment of Vestibular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-97858-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97858-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-97857-4

  • Online ISBN: 978-3-319-97858-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics